Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Olivas

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 20, 2018
Immunohistochemistry to Study YAP in Human Tissue SamplesFranziska Haderk, Victor Olivas, Trever G Bivona
The Journal of Clinical Investigation|July 23, 2019
CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programsRoss A Okimoto, Wei Wu, Shigeki Nanjo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancerRoss A Okimoto, Luping Lin, Victor Olivas, et al.
Scientific Reports|March 14, 2017
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolutionVanessa D Jonsson, Collin M Blakely, Luping Lin, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancerBeatrice Gini, Philippe Gui, Wei Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancerLuping Lin, Saurabh Asthana, Elton Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2016
Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcomaAmit J Sabnis, Christopher J Guerriero, Victor Olivas, et al.
Cancer Research|December 13, 2018
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion ProteinsDana S Neel, David V Allegakoen, Victor Olivas, et al.
Communications Biology|May 11, 2023
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinibIsmail M Meraz, Mourad Majidi, Bingliang Fang, et al.
Cell Reports|April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancerCollin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|December 20, 2018
Immunohistochemistry to Study YAP in Human Tissue SamplesFranziska Haderk, Victor Olivas, Trever G Bivona
The Journal of Clinical Investigation|July 23, 2019
CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programsRoss A Okimoto, Wei Wu, Shigeki Nanjo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2016
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancerRoss A Okimoto, Luping Lin, Victor Olivas, et al.
Scientific Reports|March 14, 2017
Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolutionVanessa D Jonsson, Collin M Blakely, Luping Lin, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancerBeatrice Gini, Philippe Gui, Wei Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Mapping the molecular determinants of BRAF oncogene dependence in human lung cancerLuping Lin, Saurabh Asthana, Elton Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2016
Combined chemical-genetic approach identifies cytosolic HSP70 dependence in rhabdomyosarcomaAmit J Sabnis, Christopher J Guerriero, Victor Olivas, et al.
Cancer Research|December 13, 2018
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion ProteinsDana S Neel, David V Allegakoen, Victor Olivas, et al.
Communications Biology|May 11, 2023
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinibIsmail M Meraz, Mourad Majidi, Bingliang Fang, et al.
Cell Reports|April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancerCollin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
Pageof 3